SCHEMBL18175060

SCHEMBL18175060

Cc1cccc(/C(N)=C/S)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.62
▸ HDAC8 Q9BY41 1/20 0.48
▸ HDAC6 Q9UBN7 1/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ HPGD P15428 2/20 0.44
▸ KCNK3 O14649 1/20 0.44
▸ KCNH2 Q12809 1/20 0.44
▸ KCNK9 Q9NPC2 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ POLB P06746 1/20 0.43
▸ ACHE P22303 1/20 0.42
▸ NPC1 O15118 4/20 0.42
▸ RAB9A P51151 4/20 0.42
▸ PKM P14618 2/20 0.42
▸ CTSL P07711 1/20 0.42
▸ CTSK P43235 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19983564 0.78 PARP1 (0.55) PARP1HDAC8HDAC6SMN1; SMN2HPGD
SCHEMBL15384452 0.78 PARP1 (0.61) PARP1TDP1ALDH1A1MAPT
SCHEMBL15384440 0.78 F2 (0.53) SMN1; SMN2MEN1KMT2ATDP1POLB
SCHEMBL20161973 0.78 PARP1 (0.48) PARP1HDAC8HDAC6SMN1; SMN2HPGD
SCHEMBL19156896 0.77 PARP1 (0.53) PARP1HDAC8HDAC6SMN1; SMN2HPGD
SCHEMBL11122251 0.77 PARP1 (0.53) PARP1HDAC8HDAC6SMN1; SMN2HPGD
SCHEMBL11122254 0.77 PARP1 (0.53) PARP1HDAC8HDAC6SMN1; SMN2HPGD
SCHEMBL19036467 0.77 PARP1 (0.53) PARP1HDAC8HDAC6SMN1; SMN2HPGD
SCHEMBL20997854 0.77 PARP1 (0.53) PARP1HDAC8HDAC6SMN1; SMN2KCNK3
SCHEMBL26345894 0.77 PARP1 (0.53) PARP1HDAC8HDAC6SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2170309-B1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL HYDRA BIOSCIENCES INC (US) 2016-10-26 — — EP disclosed
Send feedback